Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 Pogledi
• 07/17/23
0
0
Ugraditi
administrator
Pretplatnici
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari